REP PROFILE
REP PROFILE
Stacey Ellis
COMPANY
Astra Merck Inc.
TITLE
Customer group manager
CURRENT HOME
Lawrenceburg, KY
Territory: Louisville, KY
Customers: Gastrointestinologists, cardiologists, primary care physicians and internists.
Significant awards: Ellis won the Medal of Merit award three times. She also won the Pinnacle of Achievement award and the Royal Award.
On training specialists: "I coach and counsel six pharmaceutical specialists and manage half of a territory. I attend field calls with the specialists; I discuss each call with them and ask them to evaluate the success of the visit. I give constructive and positive feedback on each call. I believe in being an active participant."
On mirrored partners: "Having mirrored partners allows a company to give more coverage to their customers. Mirrored partners should discuss any issues and observations that they may have noticed in the physician's office at least once a week. The reps can work together to make sure that they meet the needs of their customers."
On being a team player: "Everyone has different strengths and qualities. Working in a team-oriented environment, reps can share their best practices, selling skills and time management skills and in turn improve their own selling skills. I meet with my territory once a month and with my district once a quarter."
Selling techniques: "I focus on the needs of my customers. I listen to them and probe them for information. I ask them about their patient population and prescription preferences. I don't use a lot of studies. I want the physicians to think of me as their resource."
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.